Stock ORIC ORIC PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart ORIC Pharmaceuticals, Inc.

Equities

ORIC

US68622P1093

Market Closed - Nasdaq
Other stock markets
 21:00:00 21/05/2024 BST 		5-day change 1st Jan Change
8.89 USD -2.09% Intraday chart for ORIC Pharmaceuticals, Inc. -2.20% -3.37%
05-06 ORIC Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-15 ORIC Pharmaceuticals Doses First Patients in Expansion Groups in Phase 1b Trial of ORIC-114 to Treat Lung Cancer MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ORIC PHARMACEUTICALS, INC. Stock ORIC Pharmaceuticals, Inc.
 599M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 22.22B -
ARGENX SE Stock argenx SE
 21.28B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 17.51B -
  1. Stock Market
  2. Equities
  3. ORIC Stock
  4. Charts ORIC Pharmaceuticals, Inc.
  5. Sector Chart